CU Cancer Center palliative care specialist Stacy Fischer, MD, is leading a National Cancer Institute–funded clinical trial testing whether guided psilocybin sessions paired with psychotherapy can reduce anxiety, depression, and existential distress in people with advanced cancer who have few effective treatment options for these symptoms.